PATHOGENESIS OF BATTEN DISEASE

$276,699P01FY2001HDNIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 29274879 Paper 27638611 Paper 26993508 Paper 26243591 Paper 26083947 Paper 25735299 Paper 25701718 Paper 25688887 Paper 25597763 Paper 25500111 Paper 25446537 Paper 25325971 Paper 25060904 Paper 24723305 Paper 24552578 Paper 24339157 Paper 24275061 Paper 24161523 Paper 23710591 Paper 23586526 Paper 22973864 Paper 22524542 Paper 22281105 Paper 21694695 Paper 21541289 Paper 21396923 Paper 21191481 Paper 21070241 Paper 20346914 Paper 20163184 Paper 19268444 Paper 19067028 Paper 18948137 Paper 18664489 Paper 18291099 Paper 18207138 Paper 17482562 Paper 17049436 Paper 16314845 Paper 16100116 Paper 15979566 Paper 15968641 Paper 15455226 Paper 15086520 Paper 14689449 Paper 12855192 Paper 12645080 Paper 12508223 Paper 12374208 Paper 12359364 Paper 12042245 Paper 12039800 Paper 11675125 Paper 11589008 Paper 11509355 Paper 11350977 Paper 11334997 Paper 11242539 Paper 11063750 Paper 11020216 Paper 10978848 Paper 10954415 Paper 10877997 Paper 10760487 Paper 10740217 Paper 10737604

Abstract

This project is aimed at understanding the biochemical pathology of Batten disease (a devastating mental retardation syndrome), using lymphoblastoid cell lines and fibroblast cultures from patients and neural tissues cultures similar to those used in the other projects. In the infantile form (CLN1) we will focus on the substrate specificity on the defective palmitoyl: protein thioesterase, the storage material and the source of this storage material from neural membrane turnover. In the late infantile form (CLN2) we will focus on the substrate specificity of the defective pepstatin-insensitive carboxyl peptidase, the storage material and its source, and in the juvenile form (CLN3) we will focus on the possible role of the protein gene product in facilitating proteolysis in the lysosome.

View original record on NIH RePORTER →